(Circulation. 1997;96:2813-2822.)
© 1997 American Heart Association, Inc.
Articles |
From the Division of Cardiology, Department of Medicine (C.D.S.) and Department of Cardiovascular Surgery (R.M.K.), Cedars-Sinai Medical Center, and University of California Los Angeles School of Medicine. J.E. Brewer is now at SurVivalink Corp, Minneapolis, Minn; Dr Kroll is now at Pacesetter Corp, Sylmar, Calif.
Correspondence to Charles D. Swerdlow, MD, Cedars-Sinai Medical Towers, 8635 W Third St, Suite 1190 W, Los Angeles, CA 90048. E-mail swerdlow{at}ucla.edu
Background Theoretical models predict that optimal
capacitance for implantable cardioverter-defibrillators (ICDs) is
proportional to the time-dependent parameter of the
strength-duration relationship. The hyperbolic model gives this
relationship for average current in terms of the chronaxie
(tc). The exponential model gives the relationship for
leading-edge current in terms of the membrane time constant
(
m). We hypothesized that these models predict results
of clinical studies of ICD capacitance if human time constants are
used.
Methods and Results We studied 12 patients with epicardial
ICDs and 15 patients with transvenous ICDs. Defibrillation threshold
(DFT) was determined for 120-µF monophasic capacitive-discharge
pulses at pulse widths of 1.5, 3.0, 7.5, and 15 ms. To compare the
predictions of the average-current versus leading-edge-current methods,
we derived a new exponential average-current model. We then calculated
individual patient time parameters for each model. Model
predictions were validated by retrospective comparison with clinical
crossover studies of small-capacitor and standard-capacitor waveforms.
All three models provided a good fit to the data
(r2=.88 to .97, P<.001). Time
constants were lower for transvenous pathways (53±7
) than
epicardial pathways (36±6
) (tc, P<.001;
average-current
m, P=.002;
leading-edge-current
m, P<.06). For
epicardial pathways, optimal capacitance was greater for either
average-current model than for the leading-edge-current model
(P<.001). For transvenous pathways, optimal capacitance
differed for all three models (P<.001). All models provided
a good correlation with the effect of capacitance on DFT in previous
clinical studies: r2=.75 to .84,
P<.003. For 90-µF, 120-µF, and 150-µF capacitors,
predicted stored-energy DFTs were 3% to 8%, 8% to 16%, and 14% to
26% above that for the optimal capacitance.
Conclusions Model predictions based on measured human
cardiac-muscle time parameter have a good correlation with
clinical studies of ICD capacitance. Most of the predicted reduction in
DFT can be achieved with
90-µF capacitors.
Key Words: defibrillation waves heart-assist device
This article has been cited by other articles:
![]() |
F. Qu, L. Li, V. P. Nikolski, V. Sharma, and I. R. Efimov Mechanisms of superiority of ascending ramp waveforms: new insights into mechanisms of shock-induced vulnerability and defibrillation Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H569 - H577. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Mowrey, Y. Cheng, P. J. Tchou, and I. R. Efimov Kinetics of defibrillation shock-induced response: design implications for the optimal defibrillation waveform Europace, January 1, 2002; 4(1): 27 - 39. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |